Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-16

Clinical Trial Update: The Effect of Dexmedetomidine Infusion Alone Versus the Combination of Dexmedetomidine and Melatonin on Reduction of Post-operative Delirium (POD) After Open Brain Surgeries [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial at Ain Shams University comparing dexmedetomidine alone versus dexmedetomidine plus melatonin for reducing postoperative delirium after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Melatonin (melatonin)

Snippet

Sponsor: Ain Shams University | Conditions: Post Operative Delerium | Phase 4 | Status: COMPLETED